Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 16.03.2026 1 AIDS 2 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 BMC Cancer 1 BMC Pediatr 8 Clin Infect Dis 7 HIV Med 1 J Acquir Immune Defic Syndr 5 J Infect Dis 2 J Virol 1 JAMA 1 Lancet 1 Nature 1 Pediatr Infect Dis J 1 Pediatrics 1 PLoS Med 8 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. TROYA J, Montes ML, Galindo MJ, Sanchez-Lopez MB, et al
   Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort.
   AIDS. 2026 Mar 10. doi: 10.1097/QAD.0000000000004484.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

2. MAZONSON P, Berko J, Lowman E, Gilliam B, et al
   Number of Sexual Partners and Patient-Reported Outcomes Among Men Age 50+ with HIV.
   AIDS Res Hum Retroviruses. 2023;39:541-546.
   PubMed         Abstract available
   
   
3. MEKURIA AD, Meseret WA, Assefa HK, Sisay AL, et al
   Time to Virological Failure and Its Predictor Among HIV-Positive Clients with the Differentiated Service Delivery Model of HIV at Debre Berhan Comprehensive Specialized Hospital, Amhara Regional State, Ethiopia, 2021: A Retrospective Cohort Study.
   AIDS Res Hum Retroviruses. 2023;39:547-557.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

4. YAO L, Tian T, Zou D, Lu X, et al
   Stepwise evolution and clonal enrichment of gepotidacin resistance in Neisseria gonorrhoeae.
   Antimicrob Agents Chemother. 2026 Mar 11:e0170625. doi: 10.1128/aac.01706.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
   Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
   BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
   PubMed        
   
   

   
   BMC Pediatr

6. OGBONNA IF, Uthman KA, Chime OH
   Battling with HIV infection in children in a resource-poor setting: an analysis of the coping strategies of the caregivers.
   BMC Pediatr. 2026 Mar 6. doi: 10.1186/s12887-026-06697.
   PubMed        
   
   

   
   Clin Infect Dis

7. SEMPERE A, Assoumou L, Gonzalez-Cordon A, Waters L, et al
   Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-02
   Clin Infect Dis. 2023;77:991-1009.
   PubMed         Abstract available
   
   
8. AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
   Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
   Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
   PubMed         Abstract available
   
   
9. MACKOW NA, Shao W, Ge L, Komarow L, et al
   Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
   Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093.
   PubMed         Abstract available
   
   
10. SCHNEIDER D, Van Bibber NW, Islam JY, Coghill AE, et al
    Progression risk in cancer patients with HIV compared to cancer patients without HIV.
    Clin Infect Dis. 2026 Mar 9:ciag170. doi: 10.1093.
    PubMed         Abstract available
    
    
11. MOE CA, Luswata RK, Barrameda AJ, Le H, et al
    Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
    Clin Infect Dis. 2026 Mar 10:ciag077. doi: 10.1093.
    PubMed         Abstract available
    
    
12. HILL A, Orkin C
    What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?
    Clin Infect Dis. 2026 Mar 11:ciag047. doi: 10.1093.
    PubMed        
    
    
13. MARTIN MA, Blenkinsop A, Moffa M, Reynolds SJ, et al
    Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.
    Clin Infect Dis. 2026 Mar 13:ciag161. doi: 10.1093.
    PubMed         Abstract available
    
    
14. FURUKAWA NW, Kamili S, Wester C
    A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States.
    Clin Infect Dis. 2026 Mar 13:ciag174. doi: 10.1093.
    PubMed        
    
    

    
    HIV Med

15. JOSEPH PE, Itaeli AM, Amour M, Bwire GM, et al
    Effects of transition from paediatric to adult HIV care on virological outcomes in sub-Saharan Africa: A systematic review and meta-analysis.
    HIV Med. 2026 Mar 13. doi: 10.1111/hiv.70221.
    PubMed         Abstract available
    
    
16. FALK S, Nilsson J, Moller IK, Elvstam O, et al
    Late diagnosis of HIV persists in Sweden: Differing social determinants among migrant and non-migrant people with HIV.
    HIV Med. 2026 Mar 12. doi: 10.1111/hiv.70217.
    PubMed         Abstract available
    
    
17. AL-KAABI M, Castley A, Deshpande P, Chopra A, et al
    The impact of accumulating immune adaptation in circulating strains of HIV-1.
    HIV Med. 2026 Mar 8. doi: 10.1111/hiv.70215.
    PubMed         Abstract available
    
    
18. LELEUX O, Peyrouny-Mazeau A, Perrier A, Hessamfar M, et al
    Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohort.
    HIV Med. 2026 Mar 7. doi: 10.1111/hiv.70220.
    PubMed         Abstract available
    
    
19. SALVO PF, Lombardi F, Torti C, Di Giambenedetto S, et al
    Clinical management of detectable viraemia during CAB/RPV long-acting therapy: Are really PIs the only exit strategies?
    HIV Med. 2026 Mar 6. doi: 10.1111/hiv.70219.
    PubMed        
    
    
20. RASTEGAR S, Gaisa MM, Xu X, Winters J, et al
    Perianal lesions in men who have sex with men living with HIV: Risk of precancer and cancer.
    HIV Med. 2026 Mar 6. doi: 10.1111/hiv.70218.
    PubMed         Abstract available
    
    
21. LUI GC, Wong GL, Yang HC, Sheng WH, et al
    Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia.
    HIV Med. 2023 Sep 21. doi: 10.1111/hiv.13545.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

22. JOHNSON A, Chimoyi L, Charalambous S, Kawaza N, et al
    Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2026 Mar 11. doi: 10.1097/QAI.0000000000003864.
    PubMed         Abstract available
    
    

    
    J Infect Dis

23. REOMA LB, Johnson TP, Cheung K, Smith BR, et al
    Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.
    J Infect Dis. 2026 Mar 6:jiag127. doi: 10.1093.
    PubMed         Abstract available
    
    
24. AYALA-SUAREZ R, Rodriguez-Agustin A, Maleno MJ, Rovira C, et al
    Changes in Cellular Senescence Biomarkers Across Individuals at Different Stages of HIV Infection Before and After a Year on Antiretroviral Therapy.
    J Infect Dis. 2026 Mar 9:jiag133. doi: 10.1093.
    PubMed         Abstract available
    
    
25. LIMA VD, Hussain SS, Yan J, Copp E, et al
    Incidence of Herpes Zoster Infection (Shingles) Among Adults Living With and Without HIV in British Columbia, Canada: A Population-Based Study.
    J Infect Dis. 2026 Mar 10:jiag118. doi: 10.1093.
    PubMed         Abstract available
    
    
26. LAMBERTI O, Ndubani R, Fitzpatrick J, Webb E, et al
    Association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia: the Schista study.
    J Infect Dis. 2026 Mar 13:jiag153. doi: 10.1093.
    PubMed         Abstract available
    
    
27. SULAIMAN A, Tamil Selvan M, Yang P, Zhu X, et al
    Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIV.
    J Infect Dis. 2026 Mar 13:jiag154. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

28. HUANG S, Zhao Y, Phillips S, Warrick JE, et al
    Erratum for Huang et al., "Single-base m(6)A epitranscriptomics reveals novel HIV-1 host interaction targets in primary CD4(+) T cells".
    J Virol. 2026 Mar 9:e0034426. doi: 10.1128/jvi.00344.
    PubMed        
    
    
29. HORVATH RM, Brumme ZL, Sadowski I
    CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells.
    J Virol. 2023;97:e0092323.
    PubMed         Abstract available
    
    

    
    JAMA

30. SCHWEITZER K
    After a Decade of Progress Against HIV, PrEP Enters a Precarious Era.
    JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1795.
    PubMed        
    
    

    
    Lancet

31. WONG N, Barnes D, Hartley J, Yunger P, et al
    Time to change internal medicine training for UK resident doctors.
    Lancet. 2026 Mar 6:S0140-6736(26)00290-4. doi: 10.1016/S0140-6736(26)00290.
    PubMed        
    
    

    
    Nature

32. 
    Monthly HIV-drug injections offer potent alternative to daily tablets.
    Nature. 2026;651:284.
    PubMed        
    
    

    
    Pediatr Infect Dis J

33. MAHTAB S, Solomon F, Chawana R, Machemedze T, et al
    Causes of Death Among Infants Who Are HIV-exposed and -Unexposed Uninfected Using Minimally Invasive Tissue Sampling in South Africa.
    Pediatr Infect Dis J. 2026;45:348-354.
    PubMed         Abstract available
    
    

    
    Pediatrics

34. RESTREPO J, Herrera T, Samakoses R, Reina JC, et al
    Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety.
    Pediatrics. 2023;152:e2022060993.
    PubMed         Abstract available
    
    

    
    PLoS Med

35. MUKASA D, Kinuthia J, Meisner A, Matemo D, et al
    Oral preexposure prophylaxis use and the risk of bacterial sexually transmitted infections and HIV among African women: A prospective observational cohort study.
    PLoS Med. 2026;23:e1004962.
    PubMed         Abstract available
    
    

    
    PLoS One

36. CASSIM N, Coetzee LM, da Silva MP, Stevens WS, et al
    Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa.
    PLoS One. 2023;18:e0292062.
    PubMed         Abstract available
    
    
37. IKEUCHI K, Fukushima K, Tanaka M, Yajima K, et al
    Changes in rapid plasma reagin titers in patients with syphilis before and after treatment: A retrospective cohort study in an HIV/AIDS referral hospital in Tokyo.
    PLoS One. 2023;18:e0292044.
    PubMed         Abstract available
    
    
38. OKUMU LA, Onguru DO, Odongo DO, Oketch JO, et al
    Factors contributing to low tuberculosis diagnosis among children aged 0-14 years in Gem Sub County in Siaya County, Kenya.
    PLoS One. 2026;21:e0335326.
    PubMed         Abstract available
    
    
39. CODDE C, Benoist C, Hocqueloux L, Delpierre C, et al
    Machine learning prediction of weight gain after antiretroviral therapy initiation in people with HIV: Insights from a large french real-world cohort.
    PLoS One. 2026;21:e0344570.
    PubMed         Abstract available
    
    
40. DESALEGN MM, Fisseha H, Altaye MG, Berhane KA, et al
    Prevalence and associated factors of non-variceal upper gastrointestinal bleeding among cirrhotic patients with upper gastrointestinal bleeding on follow-up at a Tertiary Hospital in Ethiopia.
    PLoS One. 2026;21:e0343977.
    PubMed         Abstract available
    
    
41. BORKOWSKI P, Biavati L, Nazarenko N, Parker M, et al
    Racial differences in people living with HIV and Heart Failure: Insight from New York City health and hospitals HIV Heart Failure Cohort.
    PLoS One. 2026;21:e0343710.
    PubMed         Abstract available
    
    
42. BOLTON AT, Bourdeau B, Rebchook G, Van Nuys J, et al
    Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy.
    PLoS One. 2026;21:e0341173.
    PubMed         Abstract available
    
    
43. IZUDI J, Cattamanchi A, Sekaggya-Wiltshire C, King R, et al
    Person-centered strategies for integrating TB treatment into community pharmacies for people with TB/HIV in Uganda: A human-centered design methodology study protocol.
    PLoS One. 2026;21:e0344913.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

44. GUPTA M, Waltmann C, Renner N, Wang Y, et al
    Mechanistic insights into lenacapavir-induced off-pathway HIV-1 capsid assembly.
    Proc Natl Acad Sci U S A. 2026;123:e2524995123.
    PubMed         Abstract available
    
    

    
    Science

45. COHEN J
    HIV cure bid has virus trip immune alarm.
    Science. 2026;391:1093-1094.
    PubMed         Abstract available
    
    

    
    Vaccine

46. BONI S, Quessette M, Nedelec E, Akotangni E, et al
    Human papillomavirus vaccine uptake among adolescent girls living with HIV in Cote d'Ivoire: A national cross-sectional survey.
    Vaccine. 2026;79:128434.
    PubMed         Abstract available
    
    

    
    Virology

47. HAN D, Yin W, Zhang X, Lu X, et al
    hsa-miR-181-5p inhibits human immunodeficiency virus type 1 replication by downregulating DDX3X expression.
    Virology. 2023;587:109868.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum